Works matching AU Misset, Jean-Louis


Results: 20
    1

    Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin--Cyclophosphamide Regimen.

    Published in:
    PLoS Medicine, 2007, v. 4, n. 3, p. 0585, doi. 10.1371/journal.pmed.0040090
    By:
    • Bertheau, Philippe;
    • Turpin, Elisabeth;
    • Rickman, David S.;
    • Espie, Marc;
    • Reyniés, Aurélien;
    • Feugeas, Jean-Paul;
    • Plassa, Louis-François;
    • Soliman, Hany;
    • Varna, Mariana;
    • De Roquancourt, Anne;
    • Lehmann-Che, Jacqueline;
    • Beuzard, Yves;
    • Marty, Michel;
    • Misset, Jean-Louis;
    • Janin, Anne;
    • De Thé, Hugues
    Publication type:
    Article
    2
    3
    4
    5

    Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy.

    Published in:
    1984
    By:
    • Machover, David;
    • Rappaport, Henry;
    • Schwarzenberg, Léon;
    • Misset, Jean-Louis;
    • Goldschmidt, Emma;
    • Lemaigre, Guy;
    • Dorval, Thierry;
    • de Vassal, Francoise;
    • Ribaud, Patricia;
    • Gaget, Héléne;
    • Mathe, Georges;
    • Machover, D;
    • Rappaport, H;
    • Schwarzenberg, L;
    • Misset, J L;
    • Goldschmidt, E;
    • Lemaigre, G;
    • Dorval, T;
    • De Vassal, F;
    • Ribaud, P
    Publication type:
    journal article
    6
    7
    8

    Should FDG PET/CT be used for the initial staging of breast cancer?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1539, doi. 10.1007/s00259-009-1159-0
    By:
    • Groheux, David;
    • Hindié, Elif;
    • Rubello, Domenico;
    • Espié, Marc;
    • Baillet, Georges;
    • Giacchetti, Sylvie;
    • Misset, Jean-Louis;
    • Moretti, Jean-Luc
    Publication type:
    Article
    9
    10

    Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.

    Published in:
    European Journal of Haematology, 1987, v. 38, n. S47, p. 33, doi. 10.1111/j.1600-0609.1987.tb00020.x
    By:
    • Machover, David;
    • Gastiaburu, Julio;
    • Delgado, Michel;
    • Goldschmidt, Emma;
    • Benavides, Manuel;
    • Misset, Jean-Louis;
    • Vassal, Francoise;
    • Tapiero, Haim;
    • Ribaud, Patricia;
    • Schwarzenberg, Léon;
    • Mathe, Georges;
    • Hulhoven, Reginal;
    • Lotz, Jean-Pierre
    Publication type:
    Article
    11

    Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. 873, doi. 10.1634/theoncologist.2014-0467
    By:
    • Gligorov, Joseph;
    • Pivot, Xavier B.;
    • Jacot, William;
    • Naman, Hervé L.;
    • Spaeth, Dominique;
    • Misset, Jean‐Louis;
    • Largillier, Rémy;
    • Sautiere, Jean‐Loup;
    • Roquancourt, Anne;
    • Pomel, Christophe;
    • Rouanet, Philippe;
    • Rouzier, Roman;
    • Penault‐Llorca, Frederique M.
    Publication type:
    Article
    12

    Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study.

    Published in:
    Oncologist, 2010, v. 15, n. 8, p. 799, doi. 10.1634/theoncologist.2009-0029
    By:
    • EXTRA, JEAN-MARC;
    • ANTOINE, ERIC C.;
    • VINCENT-SALOMON, ANNE;
    • DELOZIER, THIERRY;
    • KERBRAT, PIERRE;
    • BETHUNE-VOLTERS, ANNE;
    • GUASTALLA, JEAN-PAUL;
    • SPIELMANN, MARC;
    • MAURIAC, LOUIS;
    • MISSET, JEAN-LOUIS;
    • SERIN, DANIEL;
    • CAMPONE, MARIO;
    • HEBERT, CHRISTOPHE;
    • REMBLIER, CÉLINE;
    • BERGOUGNOUX, LOÏC;
    • CAMPANA, FRANK;
    • NAMER, MOÏSE
    Publication type:
    Article
    13
    14

    A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.

    Published in:
    1992
    By:
    • Lévi, Francis;
    • Misset, Jean-Louis;
    • Brienza, Silvano;
    • Adam, René;
    • Metzger, Gérard;
    • Itzakhi, Moshe;
    • Caussanel, Jean-Pierre;
    • Kunstlinger, Francis;
    • Lecouturier, Sylvie;
    • Descorps-Declère, Adrien;
    • Jasmin, Claude;
    • Bismuth, Henri;
    • Reinberg, Alain;
    • Lévi, F;
    • Misset, J L;
    • Brienza, S;
    • Adam, R;
    • Metzger, G;
    • Itzakhi, M;
    • Caussanel, J P
    Publication type:
    journal article
    15
    16
    17

    Current Issues in Adjuvant Treatment of Stage II Colon Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 6, p. 887, doi. 10.1245/ASO.2006.07.003
    By:
    • André, Thierry;
    • Sargent, Daniel;
    • Tabernero, Josep;
    • O’Connell, Michael;
    • Buyse, Marc;
    • Sobrero, Alberto;
    • Misset, Jean-Louis;
    • Boni, Corrado;
    • Gramont, Aimery
    Publication type:
    Article
    18

    When Should the Immune Clock Be Reset?

    Published in:
    Annals of the New York Academy of Sciences, 1991, v. 618, n. 1, p. 312, doi. 10.1111/j.1749-6632.1991.tb27251.x
    By:
    • LÉVI, FRANCIS;
    • CANON, CHANTAL;
    • DIPALMA, MARIO;
    • FLORENTIN, IRÈNE;
    • MISSET, JEAN-LOUIS
    Publication type:
    Article
    19
    20